Validation Data on 118 Patients Published in CancersCHICAGO, Feb. 18, 2026 /PRNewswire/ -- Belay Diagnostics, an innovative CLIA/CAP accredited laboratory ...
Summit (TM) 2.0 is a CSF-based liquid biopsy assay designed to enable comprehensive genomic profiling for characterization of CNS tumors. CNS malignancies present unique diagnostic challenges, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results